Rare hepatoid adenocarcinomas are highly heterogeneous. In this case, hepatoid adenocarcinoma occurred in both the esophagus and thyroid, and the combination of chemotherapy and immunotherapy may be a promising therapeutic tool for rare tumors. Laryngoscope, 2024.
Keywords: hepatoid adenocarcinoma; immune checkpoint inhibitors; immunohistochemistry.
© 2024 The American Laryngological, Rhinological and Otological Society, Inc.